J
Jeffrey Raizer
Researcher at Northwestern University
Publications - 138
Citations - 5053
Jeffrey Raizer is an academic researcher from Northwestern University. The author has contributed to research in topics: Bevacizumab & Temozolomide. The author has an hindex of 27, co-authored 131 publications receiving 3757 citations. Previous affiliations of Jeffrey Raizer include Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen
Eric Lancaster,Meizan Lai,Xiaoyu Peng,Ethan G. Hughes,Radu Constantinescu,Jeffrey Raizer,Daniel Friedman,Mark B. Skeen,Wolfgang Grisold,Akio Kimura,Kouichi Ohta,Takahiro Iizuka,Miguel A. Guzman,Francesc Graus,Stephen J. Moss,Rita J. Balice-Gordon,Josep Dalmau +16 more
TL;DR: GABA(B) receptor autoimmune encephalitis is a potentially treatable disorder characterised by seizures and, in some patients, associated with small-cell lung cancer and with other autoantibodies.
Journal ArticleDOI
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.
Junfei Zhao,Andrew X. Chen,Robyn D. Gartrell,Andrew M. Silverman,Luis Aparicio,Tim Chu,Darius Bordbar,David Shan,Jorge Samanamud,Aayushi Mahajan,Ioan Filip,Rose Orenbuch,Morgan Goetz,Jonathan T. Yamaguchi,Michael Cloney,Craig Horbinski,Rimas V. Lukas,Jeffrey Raizer,Ali I Rae,Jinzhou Yuan,Peter Canoll,Jeffrey N. Bruce,Yvonne M. Saenger,Peter A. Sims,Fabio M. Iwamoto,Adam M. Sonabend,Raul Rabadan +26 more
TL;DR: This study shows that clinical response to anti-PD-1 immunotherapy in GBM is associated with specific molecular alterations, immune expression signatures, and immune infiltration that reflect the tumor’s clonal evolution during treatment.
Journal ArticleDOI
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
Leland Rogers,Igor J. Barani,Marc C. Chamberlain,Thomas Kaley,Michael W. McDermott,Jeffrey Raizer,David Schiff,Damien C. Weber,Patrick Y. Wen,Michael A. Vogelbaum +9 more
TL;DR: This review summarizes the published literature regarding the treatment of newly diagnosed and recurrent meningioma with an emphasis on outcomes stratified by WHO tumor grade, and focuses on patient outcomes following treatment with surgery or radiation therapy.
Journal ArticleDOI
Central nervous system cancers: Clinical Practice Guidelines in Oncology.
Steven Brem,Philip J. Bierman,Peter M. Black,Deborah T. Blumenthal,Henry Brem,Marc C. Chamberlain,Ennio Antonio Chiocca,Lisa M. DeAngelis,Robert A. Fenstermaker,Howard A. Fine,Allan H. Friedman,Jon Glass,Stuart A. Grossman,Amy B. Heimberger,Larry Junck,Victor A. Levin,Jay J. Loeffler,Moshe H. Maor,Ashwatha Narayana,Herbert B. Newton,Alessandro Olivi,Jana Portnow,Michael D. Prados,Jeffrey Raizer,Steven S. Rosenfeld,Dennis C. Shrieve,Allen K. Sills,Alexander M. Spence,Frank D. Vrionis +28 more
TL;DR: These guidelines provide recommendations on the diagnosis and management of this group of diseases based on clinical evidence and panel consensus and include expert advice on the management of low-grade infiltrative astrocytomas, oligodendrogliomas, anaplastic gliomas, glioblastomas, medulloblastoma, supratentorial primitive neuroectodermal tumors, and brain metastases.
Journal ArticleDOI
Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review
Thomas Kaley,Igor J. Barani,Marc C. Chamberlain,Michael W. McDermott,Katherine S. Panageas,Jeffrey Raizer,Leland Rogers,David Schiff,Michael A. Vogelbaum,Damien C. Weber,Patrick Y. Wen +10 more
TL;DR: This comprehensive review confirms the poor outcomes of medical therapy for surgery- and radiation-refractory meningioma and recommends the above PFS-6 benchmarks for future clinical trial design.